Learn the details about Type 1 Diabetes. Discover the difference between Type 1 and Type 2 Diabetes, what to do about it and how to manage it.
Medtronic and Novo Nordisk announced earlier this week a collaboration to integrate insulin dosing data from future Novo Nordisk smart insulin pens
DreaMed Diabetes, a developer of personalized diabetes management solutions, announced it received U.S Food and Drug Administration (FDA) clearance
Abbott and Sanofi are partnering up to integrate glucose sensing and insulin delivery technologies that would help to further simplify how people
Abbott, a leader in sensor-based glucose monitoring, announced it has received public reimbursement in Ontario and Quebec, Canada for its
Dance Biopharm, a company developing inhaled therapies for the treatment of chronic diseases, announced today it has formed an alliance
Xeris Pharmaceuticals, Inc. announced today that it has received regulatory approval from the U.S. Food and Drug Administration (FDA) for
Medtronic today announced it has secured reimbursement for the MiniMed™ 670G insulin pump system with the German Federal Association of the
DexCom Inc., a developer of continuous glucose monitoring (CGM) systems, announced today that it is now accepting orders for the Dexcom G6 CGM
Novo Nordisk announced it will expand the company’s insulin affordability offering in the U.S. beginning on January 2, 2020. The news comes at
Senseonics Holdings, maker of the first and only long-term, implantable continuous glucose monitoring (CGM) system for people with diabetes,
Get a little dLife delivered to your inbox every week.
Leave this field empty if you’re human: